Assessment cycle 2023 Q2
Documents ratified in the 2023 Q2 assessment cycle, which ran from 1 April 2023 to 30 June 2023 and was ratified on 22 June 2023.
Documents ratified
-
Record of documents ratified in the 2023 Q2 assessment cycle.
22 Jun 2023 -
Consultation on the draft of the Institute's first analytical standard, which specifies the performance a chromatographic purity determination must achieve and states…
30 Jun 2023 -
GLP-2 receptor agonist. GLP-2 receptor agonism promotes intestinal mucosal growth, increases villus height and crypt depth, slows gastric emptying and reduces intestinal…
Moderate30 Jan 2024 -
Growth-hormone-releasing hormone analogue with albumin-binding drug affinity complex. Both variants are GHRH receptor agonists that increase pulsatile growth-hormone secretion and, downstream, IGF-1. The DAC variant…
Low14 Jul 2024 -
43-residue actin-sequestering polypeptide. Thymosin beta-4 sequesters monomeric actin and thereby regulates cytoskeletal dynamics, cell migration and wound repair. Extracellular administration…
Low13 Dec 2023 -
Melanocortin receptor agonist (cyclic heptapeptide). Bremelanotide activates central melanocortin-4 receptors, acting on hypothalamic and limbic circuits regulating sexual desire. Unlike…
Moderate15 Aug 2024 -
Sterility testing of peptide preparations presented in sealed vials
High22 Oct 2023 -
Protocol for independent third-party verification of a supplied preparation
High12 Jul 2024